A 3 ALA 0 -1.302 -1.152 <=B
A 4 PRO 3 -2.641 -2.682 <=B
A 5 LYS 3 -3.305 -3.270 <=B
A 6 SER 13 -4.874 -5.808
A 7 CYS 23 -5.830 -7.805
A 8 PRO 8 -4.526 -4.925
A 9 GLU 1 -4.051 -3.700
A 10 ARG 11 -6.689 -7.184
A 11 HIS 21 -7.888 -9.396
A 12 TYR 20 -8.005 -9.384
A 13 TRP 6 -6.863 -6.763
A 14 ALA 27 -8.125 -10.296
A 15 GLN 16 -6.584 -7.666
A 16 GLY 0 -5.564 -4.924
A 17 LYS 7 -6.075 -6.181
A 18 LEU 16 -6.877 -7.926
A 19 CYS 8 -7.709 -7.743
A 20 CYS 23 -9.431 -10.992
A 21 GLN 11 -9.381 -9.567
A 22 MET 18 -10.245 -11.137
A 23 CYS 27 -12.959 -14.574
A 24 GLU 3 -11.667 -10.670
A 25 PRO 8 -12.468 -11.954
A 26 GLY 4 -14.496 -13.289
A 27 THR 17 -13.710 -14.089
A 28 PHE 14 -14.162 -14.144
A 29 LEU 24 -13.881 -15.045
A 30 VAL 8 -12.819 -12.264
A 31 LYS 5 -10.284 -9.676
A 32 ASP 14 -9.786 -10.270
A 33 CYS 21 -9.159 -10.521
A 34 ASP 2 -6.540 -6.018
A 35 GLN 2 -6.736 -6.191
A 36 HIS 6 -6.356 -6.315
A 37 ARG 2 -6.160 -5.682
A 38 LYS 9 -7.345 -7.535
A 39 ALA 9 -9.461 -9.408
A 40 ALA 31 -10.796 -13.119
A 41 GLN 4 -11.355 -10.509
A 42 CYS 30 -14.074 -15.906
A 43 ASP 7 -13.062 -12.365
A 44 PRO 7 -12.751 -12.090
A 45 CYS 31 -15.974 -17.702
A 46 ILE 6 -14.399 -13.433
A 47 PRO 0 -14.520 -12.851
A 48 GLY 1 -17.295 -15.421
A 49 VAL 6 -17.293 -15.995
A 50 SER 13 -16.284 -15.906
A 51 PHE 16 -16.574 -16.508
A 52 SER 22 -16.925 -17.508
A 53 PRO 9 -14.907 -14.227
A 54 ASP 7 -10.314 -9.933
A 55 HIS 10 -10.210 -10.186
A 56 HIS 20 -11.338 -12.334
A 57 THR 18 -11.837 -12.546
A 58 ARG 19 -11.621 -12.469
A 59 PRO 4 -12.325 -11.368
A 60 HIS 4 -13.482 -12.392
A 61 CYS 27 -15.809 -17.096
A 62 GLU 21 -15.307 -15.962
A 63 SER 3 -18.090 -16.355
A 64 CYS 24 -20.539 -20.937
A 65 ARG 22 -18.359 -18.778
A 66 HIS 3 -17.960 -16.240
A 67 CYS 18 -19.982 -19.754
A 68 ASN 11 -16.833 -16.162
A 69 SER 15 -15.471 -15.416
A 70 GLY 22 -17.532 -18.046
A 71 LEU 7 -17.636 -16.413
A 72 LEU 11 -20.015 -18.979
A 73 VAL 13 -18.358 -17.741
A 74 ARG 11 -17.631 -16.868
A 75 ASN 6 -17.316 -16.014
A 76 CYS 22 -20.278 -20.476
A 77 THR 7 -16.703 -15.587
A 78 ILE 15 -15.204 -15.181
A 79 THR 6 -14.460 -13.487
A 80 ALA 7 -16.792 -15.666
A 81 ASN 14 -19.251 -18.647
A 82 ALA 24 -19.428 -19.954
A 83 GLU 6 -19.113 -17.605
A 84 CYS 20 -20.493 -20.436
A 85 ALA 6 -17.724 -16.375
A 86 CYS 13 -16.387 -15.998
A 87 ARG 4 -12.966 -11.935
A 88 ASN 0 -9.412 -8.330
A 89 GLY 0 -8.977 -7.945
A 90 TRP 18 -10.198 -11.095
A 91 GLN 1 -10.395 -9.315
A 92 CYS 14 -14.118 -14.104
A 93 ARG 8 -11.574 -11.163
A 94 ASP 12 -12.461 -12.408
A 95 LYS 2 -13.051 -11.780
A 96 GLU 14 -16.527 -16.236
A 97 CYS 16 -17.398 -17.237
A 98 THR 10 -17.947 -17.033
A 99 GLU 3 -14.956 -13.581
A 100 CYS 18 -13.955 -14.421
A 101 ASP 5 -10.065 -9.482

Identified 3 B-Cell epitope residues out of 99 total residues